磷脂酰丝氨酸
血小板
细胞凋亡
细胞生物学
细胞外
凝血酶
血小板活化
化学
钙
磷脂酶
生物
药理学
生物化学
免疫学
膜
磷脂
有机化学
作者
Simone M. Schoenwaelder,Yuping Yuan,Emma C. Josefsson,Michael J. White,Yao Yu,Kylie D. Mason,Lorraine Ann O’Reilly,Katya J. Henley,Akiko Ono,Sarah Tzu-Feng Hsiao,Abbey Willcox,Andrew Warwick Roberts,David C.S. Huang,Hatem H. Salem,Benjamin T. Kile,Shaun P. Jackson
出处
期刊:Blood
[Elsevier BV]
日期:2009-04-23
卷期号:114 (3): 663-666
被引量:314
标识
DOI:10.1182/blood-2009-01-200345
摘要
Procoagulant platelets exhibit hallmark features of apoptotic cells, including membrane blebbing, microvesiculation, and phosphatidylserine (PS) exposure. Although platelets possess many well-known apoptotic regulators, their role in regulating the procoagulant function of platelets is unclear. To clarify this, we investigated the consequence of removing the essential mediators of apoptosis, Bak and Bax, or directly inducing apoptosis with the BH3 mimetic compound ABT-737. Treatment of platelets with ABT-737 triggered PS exposure and a marked increase in thrombin generation in vitro. This increase in procoagulant function was Bak/Bax- and caspase-dependent, but it was unaffected by inhibitors of platelet activation or by chelating extracellular calcium. In contrast, agonist-induced platelet procoagulant function was unchanged in Bak(-/-)Bax(-/-) or caspase inhibitor-treated platelets, but it was completely eliminated by extracellular calcium chelators or inhibitors of platelet activation. These studies show the existence of 2 distinct pathways regulating the procoagulant function of platelets.
科研通智能强力驱动
Strongly Powered by AbleSci AI